Beacon Pointe Advisors’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-993
| Closed | -$200K | – | 1069 |
|
|
2022
Q3 | $200K | Sell |
993
-2,423
| -71% | -$488K | ﹤0.01% | 929 |
|
|
2022
Q2 | $727K | Sell |
3,416
-1,980
| -37% | -$421K | 0.02% | 550 |
|
|
2022
Q1 | $1.53M | Buy |
5,396
+4,462
| +478% | +$1.27M | 0.02% | 508 |
|
|
2021
Q4 | $352K | Sell |
934
-8,846
| -90% | -$3.33M | 0.01% | 673 |
|
|
2021
Q3 | $4.04M | Buy |
+9,780
| New | +$4.04M | 0.1% | 191 |
|